Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced vs Extended Antibiotic Prophylaxis for RIRS
NCT05384197Phase 3Unknown
- Sponsor
- Mansoura University
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of trimethoprim + sulfamethoxazole in post-operative infection (2 arms), sponsored by Mansoura University. Primary endpoint: Rate of postoperative sepsis at 30 days. Status: unknown.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT05384197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384197.